Internship

Summer 2025 – Pharmaceutical Candidate Optimization and Nonclinical Safety/Veterinary Sciences Inte…

Posted on 9/17/2024

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

Compensation Overview

$21 - $29Hourly

Boston, MA, USA + 5 more

More locations: Seattle, WA, USA | Summit, NJ, USA | Franklin Township, NJ, USA | Princeton, NJ, USA | San Diego, CA, USA

Roles may require onsite presence based on occupancy structure.

Category
Veterinary Professionals
Medical, Clinical & Veterinary
Requirements
  • Undergraduate student, enrolled in an academic program for the Fall of 2025, with demonstrated interest and effort within biology, chemistry, toxicology, computational sciences, pharmaceutical sciences, material sciences, biomedical engineering, veterinary science and related disciplines.
  • Undergraduate student should have continued interest in pursuing academic endeavors or a career in the sciences after graduation.
  • Availability for full-time employment (40 hrs/week) throughout the 10-week internship period of June 2, 2025 to August 8, 2025.
Responsibilities
  • Directly contribute to assigned project with manager support, which is aligned with PCO and NCS/VS responsibilities and student experiences/goals.
  • Responsibilities will vary with assigned project, but can include laboratory work, literature/data review, use of AI tools, computer programming and/or computational analyses.
  • Active participation in informal networking/mentor meetings and formal symposiums.
  • Presentation of overall project and scientific findings at the conclusion of the internship.

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's collaboration with AI Proteins could lead to novel miniprotein-based therapeutics.
  • The $3.5bn agreement with Prime Medicine enhances BMS's cell and gene-therapy pipeline.
  • Karen Costello's appointment may strengthen BMS's commercial strategy in Ireland.

What critics are saying

  • BMS faces legal challenges, including a lawsuit against HRSA and HHS.
  • The dismissal of a $6.4 billion lawsuit could impact BMS's financial standing.
  • Regulatory hurdles may delay the approval of new drugs, affecting market entry.

What makes Bristol-Myers Squibb unique

  • BMS focuses on oncology, immunology, and cardiovascular diseases for innovative treatments.
  • The company invests heavily in R&D to develop new drugs and therapies.
  • BMS offers both innovative and generic medicines, increasing healthcare accessibility.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE